Featured Research

from universities, journals, and other organizations

Protein that keeps people, skeletons organized

Date:
November 14, 2013
Source:
University of Southern California - Health Sciences
Summary:
Most people think that their planners or their iPhones keep them organized, when in fact, proteins such as liver kinase b1 actually have a lot more to do with it. New research sheds light on how this important protein keeps people organized on a basic level by promoting orderly skeletal growth and preventing skeletal tumors.

Mouse femur with an enchondroma-like structure.
Credit: Lick Lai

Most people think that their planners or their iPhones keep them organized, when proteins such as liver kinase b1 (Lkb1) actually have a lot more to do with it. New research from postdoctoral fellow Lick Lai in the lab of USC scientist Andy McMahon published in Proceedings of the National Academy of Sciences (PNAS) sheds light on how this important protein keeps people organized on a basic level by promoting orderly skeletal growth and preventing skeletal tumors.

In a developing embryo, many bones form based on cartilage templates. The study found that to form these templates, Lkb1 protein controls the progression of immature, dividing cartilage cells into larger, mature and fully differentiated cartilage cells. Without Lkb1, the population of immature cartilage cells disproportionately increases, leading to skeletal tumors.

The way that Lkb1 controls the differentiation of cartilage cells is by suppressing what's known as the "mammalian target of rapamycin (mTOR) pathway" -- a very important complex of molecules that coordinates growth in response to available nutrients and other factors. Problems with the mTOR pathway have been implicated in a host of human diseases, including diabetes, obesity, depression and many cancers.

The influence of abnormal Lkb1 isn't restricted to the skeleton, however. Mutant forms of Lkb1 are frequently present in patients with lung, cervical, breast, intestinal, testicular, pancreatic and skin cancers, and in patients with the Peutz-Jeghers syndrome, characterized by benign polyps in the gastrointestinal tract.

"By understanding Lkb1 and the mechanisms that control normal skeletal development, we also learn how we might prevent this development from going awry in cancers and other disorders," said McMahon, who directs the USC Stem Cell initiative and the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC.


Story Source:

The above story is based on materials provided by University of Southern California - Health Sciences. The original article was written by Cristy Lytal. Note: Materials may be edited for content and length.


Journal Reference:

  1. L. P. Lai, B. N. Lilley, J. R. Sanes, A. P. McMahon. Lkb1/Stk11 regulation of mTOR signaling controls the transition of chondrocyte fates and suppresses skeletal tumor formation. Proceedings of the National Academy of Sciences, 2013; DOI: 10.1073/pnas.1309001110

Cite This Page:

University of Southern California - Health Sciences. "Protein that keeps people, skeletons organized." ScienceDaily. ScienceDaily, 14 November 2013. <www.sciencedaily.com/releases/2013/11/131114094947.htm>.
University of Southern California - Health Sciences. (2013, November 14). Protein that keeps people, skeletons organized. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/11/131114094947.htm
University of Southern California - Health Sciences. "Protein that keeps people, skeletons organized." ScienceDaily. www.sciencedaily.com/releases/2013/11/131114094947.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins